PEG and RGD modifications of HK enhance gene
silencing in tumor
xenografts. Luciferase siRNA nanoplexes with unmodified, PEG or RGD-PEG
(RP) modified H3K(+H)4b were systemically administered to tumor xenografts
bearing mice. Before and 48 h after treatment, luciferase activity
was determined by an IVIS 200 system. The data represent the mean
± SD of luciferase of four determinations for each carrier. *, P < 0.05; **, P < 0.01; ***, P < 0.001.